Related Experiment Video
Updated: Jan 9, 2026
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Survival analysis of risk factors for mortality in pulmonary tuberculosis patients in southeast Iran (2013-2023)
Maryam Rastegar1,2, Zahra Arab Borzu3, Abolfazl Payandeh4
1Department of Epidemiology and Biostatistics, School of Health, Zahedan University of Medical Sciences, Zahedan, Iran.
Background:
Tuberculosis (TB) remains a major global health challenge, particularly in low- and middle-income countries. In Iran, Sistan-and-Baluchistan Province bears a disproportionately high burden of pulmonary tuberculosis due to its geographic, socioeconomic, and healthcare access-related vulnerabilities. Despite national control programs, evidence on survival outcomes and mortality predictors in this region remains limited.
Objective:
This study aimed to determine the survival time and identify key risk factors associated with mortality among smear-positive pulmonary tuberculosis (SPPTB) patients in Sistan-and-Baluchistan Province, southeast Iran.
Methods:
In this retrospective cohort study, data from 7,234 SPPTB patients were collected from 2013 to 2023. Information was analyzed using Kaplan-Meier survival estimates, log-rank tests, and multivariable Cox proportional hazards models. Survival time was calculated from the date of the SPPTB diagnosis to the date of death or censoring due to treatment completion, cure, failure, or loss to follow-up. Statistical analyses were conducted using SPSS version 22, with significance set at p < 0.05.
Results:
Among the study population, 526 patients (7.3%) died during treatment. The median survival time was 20.5 months (95% CI: 12.15-28.54). The findings revealed that advanced age, prisoner status, low BMI, Iranian nationality, rural residency, and HIV co-infection were significant predictors of mortality.
Conclusion:
The study highlights several key risk factors associated with SPPTB-related mortality in a high-burden region of Iran. These findings emphasize the need for targeted interventions, particularly for elderly, malnourished, HIV-positive, and incarcerated individuals, as well as the integration of nutritional and HIV care into SPPTB control programs. Early detection, improved follow-up, and structural support in underserved settings are essential to reduce mortality and align with WHO End TB Strategy targets.
Clinical Trial Number:
Not Applicable.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:21Cancer Survival Analysis
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:15Assumptions of Survival Analysis
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: